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Abstract
Background: Qualitative methods are increasingly used to study the process of clinical trials and patients understanding
of the rationale for trials, randomisation and reasons for taking part or refusing. Patients' understandings are inevitably
influenced by the recruiting clinician's understanding of the trial, yet relatively little qualitative work has explored
clinicians' perceptions and understandings of trials. This study interviewed surgeons shortly after the multi-centre,
pragmatic RCT in which they had participated had been completed.
Methods: We used in-depth interviews with surgeons who participated in the Spine Stabilisation Trial (a pragmatic RCT)
to explore their understanding of the trial purpose and how this understanding had influenced their recruitment
procedures and interpretation of the results. A purposive sample of eleven participating surgeons was chosen from 8 of
the 15 UK trial centres.
Results: Although the surgeons thought that the trial was addressing an important question there was little agreement
about what this question was: although it was a trial of 'equivalent' treatments, some thought that it was a trial of surgery,
others a trial of rehabilitation and others that it was exploring what to do with patients in whom all other treatment
options had been unsuccessful. The surgeons we interviewed were not aware of the rationale for the pragmatic inclusion
criteria and nearly all were completely baffled about the meaning of 'equipoise'. Misunderstandings about the entry
criteria were an important source of confusion about the results and led to reluctance to apply the results to their own
practice.
Conclusion: The study suggests several lessons for the conduct of future multi-centre trials. Recruiting surgeons (and
other clinicians) may not be familiar with the rationale for pragmatic designs and may need to be regularly reminded about
the purpose during the study. Reassurance may be necessary that a pragmatic design is not considered a design fault. We
conclude that it does matter if clinicians do not understand the rationale for the trial if, as we have shown here, their
perception of the trial aims and methods adversely affects who they recruit; if their views affect what the patients are
told; and if they mistakenly view the results as unscientific, unreliable and ultimately irrelevant to their practice.
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Background
Qualitative research methods are used increasingly to
study the process of RCTs. Such studies have predomi-
nantly involved assessment of patient participants' experi-
ences of consent, and their understanding of trial design
and random allocation [1]. Research addressing these
same issues for clinician participants is rare. This is partic-
ularly the case for surgeons, in spite of the fact that com-
mentators have suggested that surgical RCTs are
particularly problematic. Reviews conducted from the
mid 1960s onwards have consistently indicated that RCTs
are less common in surgery [2-5]. The quality of surgical
RCTs and the standard of their reports are often consid-
ered to be low [6-9].
Several authors contend that the culture and mindset of
surgeons may be highly influential. Stirrat [10] suggests
that surgeons are relatively less involved in RCT participa-
tion and draw less upon RCT findings to inform and affect
their practice. This may be a residual effect of traditional
education [11] and a lack of emphasis on the use of the
RCT [12] and epidemiological methods training [13]. In
the surgical environment there is a preference for non-ran-
domised studies [5,11] and an informal approach to
innovation and research is tolerated [14-16]. Surgeons
may be influenced by individual cases with particularly
good or bad results. Maddern refers to the impact of "the
surgical temperament" which he suggests "does not
always lead to well-developed team skills among sur-
geons" [17] and McCulloch and colleagues argue that
traits which are advantageous in a surgeon, namely "com-
fort with making important decisions quickly with incom-
plete information", may make it less likely that they will
be in a state of equipoise, that is "consciously uncertain
which of two treatments is better" [18].
Given these concerns it is surprising that surgeons' reac-
tions to RCTs and their understanding of the methods
involved have received so little empirical attention. One
study found UK surgical oncologists to be less research
oriented than radiation and medical oncologists and
more likely to "rely on clinical experience rather than
enter patients into a trial" [19]. Surgeons placed less
emphasis on association with research, publishing papers,
acting as a principal investigator, and having a national or
international reputation. They were more likely to feel
that hospital-based doctors were given greater rewards for
work with patients than for research contributions.
Another study of French surgeons, found older surgeons
less likely to participate and to use trial results than their
younger counterparts [20,21].
These studies suggest some support for the views of the
commentators on surgical trials, but further attitudinal
and experiential research is needed. It is important to con-
sider how surgeons understand and respond to their
involvement in specific trials and to explore how this
might affect both recruitment and utilisation of research
findings. Qualitative research methods cannot be used to
explore cause and effect – for example whether particular
clusters of views predict different recruitment rates – but
they are ideal for explorative studies that aim to identify
perceptions and uncover meanings. This paper reports the
views of surgeon participants in the Spine Stabilisation
Trial (SST) and explores whether clinicians awareness of
the study purpose and rationale is likely to be important.
The Spine Stabilisation Trial (SST)
This multi-centre MRC-funded RCT compared an inten-
sive functional rehabilitation programme (FRP) with spi-
nal fusion surgery for treatment of chronic low back pain
and has recently reported results [22,23]. Spinal fusion for
back pain was considered 'the most controversial surgery'
in the area of spinal surgery. The SST was a pragmatic
rather than an experimental trial, and a particular aim was
to assess the interventions in exactly the variable clinical
contexts in which they would be used.
The pragmatic design developed from discussions at pre-
trial orthopaedic meetings at the Nuffield Orthopaedic
Centre, Oxford with contributions from a number of spi-
nal surgeons. The original plan was to conduct an RCT of
surgery with a control arm of non-treatment or delayed
treatment. It was ultimately decided that an alternative,
equivalent treatment should be offered. As trials identify-
ing the efficacy of FRP had already been conducted at
Oxford, it was decided to include this as an equivalent
treatment. Defining clinical criteria for trial entry was a
major problem for the SST designers, even with access to
literature reviews, and formal meetings with specialist col-
laborators. As surgeons across the UK vary greatly in their
use of spine stabilisation there was clearly no consensus
over the most appropriate patients for this form of sur-
gery. The trial was therefore designed to reflect the variety
inherent in clinical practice. The patients who were eligi-
ble for the trial were therefore a clinically varied group;
aged 18 to 55 with more than a 12 month history of back
pain where standard non-operative treatment had failed,
about whom the surgeons were uncertain whether spinal
fusion or FRP would be the best option.
Recruitment was slow and the numbers enrolled smaller
than planned. Fifteen UK centres recruited 349 partici-
pants, a third of those originally anticipated. Despite a
small sample, secondary power analyses had demon-
strated that, with an unexpectedly limited spread of diag-
nosis (one of the stratification variables for
randomisation), the trial was adequately powered. There
were sufficient data to analyse and interpret the primary
outcomes for the "Chronic Pain Group", but insufficient
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numbers to explore these outcomes in the "Spondy-
lolisthesis Group" or the "post-laminectomy Group".
Methods
The purposive sample for this qualitative study was
selected to represent different rates of institutional
involvement with SST and geographical spread. The
recruitment rates for the 15 SST centres were categorised
as high, medium and low. Eleven surgeons from eight
high, medium and low centres from the South, Midlands
and North, were invited to take part in individual, face to
face interviews. None refused. Their personal recruitment
rates ranged from 0–63 randomised patients and have for
this analysis been categorised as high, medium or low.
With informed consent interviews were conducted by a
qualitative researcher (DP) with a social science back-
ground and experience of interviewing surgeons. Inter-
views took place during 2004 after the main trial results
were presented at an orthopaedic conference but before
publication. Qualitative thematic analysis was conducted
by two social scientists (SZ, KF) who read and independ-
ently coded transcripts and discussed interpretation of the
data in a series of meetings and email exchanges with the
other authors. Level of agreement was not compared sta-
tistically. As is usual in qualitative research differences of
interpretation tended to be subtle and were resolved by
discussion. Anticipated and emergent themes in the data
were analysed using constant comparison and examina-
tion of deviant cases [24].
Surgeons were asked their opinion of the SST's research
question as well as questions about the purpose and
design of the trial; how they became involved; their
recruitment procedures including explaining randomisa-
tion and uncertainty; their understanding of equipoise
and uncertainty in relation to SST; interpretation of SST
results, and what might have made the trial easier to con-
duct. Here we focus on surgeons' understanding of the
design and purpose and interpretation of the trial results.
The study was approved by Eastern MREC. Because ortho-
paedic surgery is a relatively close knit community in the
UK we have taken particular care to ensure that the quota-
tions, which illustrate the main themes, are fully ano-
nymised. Therefore when presenting quotes from the
surgeons we specify only whether their personal recruit-
ment level was 'high' 'medium' or 'low'.
Results
The use of RCT methods
The surgeons expressed positive views of the use of RCTs
for examining the effects of medical interventions. Nearly
all said that the SST addressed an important question,
involved an experienced and respected research team and
used the 'gold standard' research method:
It was well thought out. You know a lot of work was put into it.
I mean we had two collaborators meeting; we had a hundred
statisticians ferreting about so yes I think the design was good.
Surgeon with low personal recruitment
There were however reservations about the SST design,
despite positive views of RCTs in general. For example one
surgeon wondered if there are better ways to gather relia-
ble data about surgery in a shorter time frame and sus-
pected that the RCT was used because it was 'politically
correct'.
The surgeons were asked what they understood by 'equi-
poise' and 'uncertainty principle' in relation to the SST.
Nearly all were unclear on the meaning of 'equipoise'.
Although uncertainty was a familiar term, surgeons often
related it to the outcomes of any surgery for an individual
rather than to the specific comparison of interventions in
a trial, here spinal fusion and the FRP (Functional Reha-
bilitation Programme).
(Mis) understandings about trial design
It became clear that the surgeons held different views of
the purpose and design of the SST. Surgeons were often
unsure of the trial aims, were unclear about the nature of
the comparison, and expressed concerns about flexible
entry criteria.
The purpose of the SST was to compare surgery to an
intensive functional rehabilitation programme (FRP) for
treatment of chronic low back pain. However, most of the
surgeons we interviewed saw it as a trial of surgery, some
thought it was a trial of rehabilitation, and others sug-
gested a much broader remit.
I just thought it was a way of sort of trying to work out what's
the best treatment for patients, with back problems, that you
didn't know what to do with. Surgeon with low personal
recruitment
[They] had the great [pause] foresight to actually ask a ques-
tion which is you know, it's the big question that is in front of
us every day when we come to work. Does surgery work? Is it
worth doing? You know, that was, what, what, what bigger
question can you ask? Surgeon with medium personal recruit-
ment
None of the surgeons interviewed stated that it was
designed to compare two 'equivalent' treatments,
although this was a key feature of the trial. Many eligible
patients had already received extensive physiotherapy and
the surgeons described the need to 'dress up', 'talk up' or
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'sex up' the FRP arm as something different or new. Some,
in contrast, said that they presented FRP as the 'control' or
'conservative arm' in their recruitment 'spiel'.
The SST involved a pragmatic design, comparing interven-
tions as used in clinical practice, rather than in the rigid
and artificial circumstances created by explanatory trials.
Broad eligibility criteria reflected the fact that surgeons,
within and without the trial, vary in their views of which
patients might benefit from surgery (several commented
on the large difference in the numbers of fusions per-
formed by UK spinal surgeons). The pragmatic design was
not understood by the surgeons. Several expressed con-
cern what they perceived as an unfortunate variability in
the SST sample and expected that colleagues' perceptions
of eligible patients would be different from their own.
They talked about psychological and social factors in
selecting patients for spinal fusion and the 'art', 'instinct'
and 'eye' of the surgeon. Although only consultant-grade
specialist surgeons identified candidates for the SST, vari-
ations in skill and preferences caused concern. The inclu-
sion of patients with a range of clinical presentations left
some feeling that the SST used a flawed design which
would render the results unsound or irrelevant to their
own practice. One surgeon argued that the broad inclu-
sion criteria loaded the trial against spinal fusion and that,
counter to standard trial procedures, they should have
been highly selective:
[If] you want to come out with an answer which says 'spinal
fusion works for a selected group of patients', you select the
patients very, very carefully for those patients whom you have
the least uncertainty for offering the fusion. .... I think that if
you actually bias the selection of patients going into the trial to
the patients who, in whom the outcome was seen at the begin-
ning to be most uncertain, then you are going to end up with a
load of bad apples in the trial who aren't going to do terribly
well and I think that's why a lot of surgeons weren't – were
fairly diffident about going into it at the beginning. Surgeon
with medium personal recruitment
Others also thought the trial was biased against spinal
fusion because the 'uncertainty of outcome principle'
meant that the most 'promising' patients would have been
excluded by their surgeon i.e. they would be given spinal
fusion outwith the trial. As one put it 'It's not the test of spi-
nal fusion. It's a test of spinal fusion in a group of patients
nobody knows what to do with'. One consultant suspected
that others, like himself, would also take the psychologi-
cal, social and intellectual profile of potential participants
into account when recruiting. Several surgeons felt that
these difficulties and problems with recruitment and
retention affected the validity of the trial.
These views may have affected the SST. Some surgeons
indicated that when recruitment difficulties became pub-
lic, they had wondered if there was any point in maintain-
ing their recruitment efforts if the trial was destined to
'close early'.
Making sense of the trial results
The SST allowed recruiting surgeons to exercise clinical
judgement. The variation in the rates of fusion surgery
amongst surgeons, differences in their perceptions of
appropriate surgical candidates and in preferred operative
techniques, were all accommodated in the trial design.
This inherent flexibility did, however, leave many unsure
how to interpret the results. Some of the accounts sug-
gested that there had been considerable discussion within
the orthopaedic community about the study and the dan-
ger of 'bias' in the design. One surgeon commented: "We
all thought the trial would rather go against spinal fusion
because you are recruiting patients with a high degree of uncer-
tainty." Surgeon with medium personal recruitment
As the SST results had not been published at the time of
the interviews, surgeons had not had an opportunity to
examine them in detail, but most had received some
information about the findings. The principal investiga-
tor, Jeremy Fairbank, had presented the findings at a con-
ference and to some colleagues individually. Everyone we
interviewed felt they knew the main findings, however,
only one surgeon was able to demonstrate a good under-
standing of the results:
Rehabilitation is more or less as effective as surgery in the treat-
ment of chronic lower back pain in a particular group of
patients. That's number one. Number two, recommendations
for the future are that people with chronic lower back pain in
this situation go and have a rehabilitation programme. If they
fail that then it may be appropriate to treat as surgery. We don't
know the answer to that. Surgeon with high personal recruit-
ment
Those who accepted that the short-term follow-up
showed no real difference between the treatment arms
concluded that rehabilitation was a viable and cheaper
option. Some of these surgeons were keen to use the
results of the study to support their campaigns for better
rehabilitation programmes within their Hospital Trusts,
although there were also concerns that the results might
be misinterpreted or 'misread' as suggesting that spinal
fusion should not be funded.
I suspect that some of the PCTs (primary care trusts) will look
at it and say 'Well we should stop spine surgery'. But on the
optimistic side, some people may look at it and say 'Well look
spine surgery should therefore be used for the physiotherapy fail-
ures', which begs the question of 'Why should surgery in that
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sense be any better?' So like all research you have some ques-
tions answered that throws up some more. Surgeon with low
personal recruitment
The results could also be used to persuade patients that
surgery might not be the best option, for example, one
surgeon said that the results would help him to recom-
mend his patients complete FRP before considering sur-
gery. However, some stressed that the results would not
change their practice, because they had always presented
the outcomes of spinal fusion as 'very uncertain'.
Concerns about the design and conduct of the SST, largely
based on misunderstandings about the nature of the trial,
meant that not all participating surgeons accepted the
results. A low recruiting surgeon, clearly unconvinced that
the trial was adequately powered, suggested that a bigger
trial was needed to find a significant difference between
the two treatments. Some were disappointed that the trial
did not come down firmly in favour of one treatment or
expressed disappointment that the trial did not identify
which patients would be likely to benefit most from spi-
nal fusion (something which was outside the remit of the
SST). A common belief was that the results did not apply
to their practice. A surgeon who saw the trial as 'not that
valid' described treatment for back pain as 'a personal
journey between you and the patient' and suggested that:
[As] long as you have audited your own practice, and you can
show that in your own practice that patients who have fusions,
in general, do get very good outcomes, then it's perfectly ethical
to continue to do. Surgeon with medium personal recruitment
Collaboration with the trial had motivated many of these
surgeons to reflect upon and compare aspects of their
practice. Some thought it might be more relevant to real
patients and practice to pool routine, anonymised,
national and international audit data that would enable
them to compare and evaluate their practice.
Discussion
The study adds to the scant literature on clinician's per-
spectives and understandings of trials. It reports how a
small, purposively sampled, group of surgeons who had
recently taken part in a specific clinical trial perceived
both the trial methods and the results. The study suggests,
in line with much of the non-empirical literature, that tri-
als in a surgical context can be particularly challenging.
One aspect of this challenge may relate to the views of sur-
geons themselves and their understandings of the trial
design.
The study was funded after the trial was complete; hence
all interviews with surgeons took place as soon as possible
after the trial closed A qualitative study running concur-
rently with the trial – especially if it had included observa-
tions of recruitment procedures – would likely have
yielded additional material, yet might have raised the sur-
geons' awareness of the trial objectives and rationale.
While this might have been beneficial from the SST per-
spective, the follow-up design identified some quite major
misunderstandings that could be averted in future multi-
centre trials. We were also able to explore the participants
interpretation of the early results and the implications for
their practice.
Because of existing controversy on the subject of surgical
spinal fusion equipoise was explicitly built into the trial
design. Surgeons were asked to recruit patients for whom
they personally were uncertain whether spinal fusion or
FRP would be the best option. However, the role and
importance of equipoise and the 'uncertainty principle' in
this situation was not well understood by most of the sur-
geons. This may in part relate to the fact that they were
used to using the term "uncertainty" in a rather different
way, relating to the unpredictable nature of any surgical
procedure for any patient. This is in contrast with a study
of neonatologists where almost all used the concept of
equipoise or uncertainty in their interview and seemed to
find them useful in trial-related practice [25].
Many of the surgeons were concerned that a patient's eli-
gibility for the trial was dependent on the recruiting sur-
geon's opinion on their suitability for surgery rather than
a clearer set of inclusion and exclusion criteria. Although
this is a key feature of pragmatic designs, this was an
important issue for the surgeons as it appeared to define
the standards of the research. It also undermined the cred-
ibility of the results for those who felt that the design of
the trial was stacked against spinal fusion from the start,
through the inclusion of patients who may be less likely
to benefit from surgery. The concerns expressed here echo
the pre-trial difficulties in defining appropriate entry crite-
ria for the SST. Whilst the pragmatic element of the design
was intended to reflect current practice and variation, this
was widely misunderstood. As the surgeons who we inter-
viewed seemed to view the completed trial as explanatory
rather than pragmatic, the design appeared to fall short of
the highly controlled standards that they expected from
experimental research [26].
Confusion among these surgeons about the aims of the
trial and the perceived imprecision of the eligibility crite-
ria meant that many were unconvinced that the sample of
trial participants were representative of their patients. This
may in part relate to pre-existing preferences for non-ran-
domised research, as suggested by some commentators,
but it has also been suggested that surgeons may be partic-
ularly distrustful of the applicability of trial results for
individual patients within their own practice. Stirrat sug-
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gests that in order to justify carrying out invasive proce-
dures, "the surgeon [has] to travel further along the road
of self-belief than his physician colleagues." He argues
that as a result they may be less likely to be reflexive than
other physicians, and are used to viewing patients as indi-
viduals rather than as part of a population or community,
factors which may reduce faith in the value of RCTs [10].
Buchwald claims that some methods that are fundamen-
tal to the conduct of trials, can be alien concepts for many
surgeons [11].
Conclusion
The SST trialists performed according to current good
practice guidelines, for example holding collaborators
meetings and producing a video to explain the rationale
for the trial. However, by the end of the trial some of the
key characteristics of the trial were not recalled by partici-
pating surgeons. Recruitment took place between 1996
and 2002, which is a long time to hold the interest of
treating clinicians. We do not suggest that the SST was a
poorly conducted trial, rather that this opportunity to
explore surgeons' (mis)understandings of the trial has
allowed us to identify issues with broad application for
clinical trials.
This qualitative study suggests several lessons for the
design and conduct of future multi-centre trials. Knowl-
edge of the principles of trial design and the differences
between pragmatic and explanatory trials amongst clini-
cians at any level should not be taken for granted. In the
SST misunderstandings about the entry criteria were an
important source of confusion about the applicability of
the results. Trialists should be clearer about which
patients can be included and why, and should explain to
recruiting clinicians that trial statisticians are able to con-
trol for patient variation. This point – and others – will
likely need to be reinforced during the conduct of a trial
that lasts for several years. It is the responsibility of trialists
to ensure that training on the specific aims of the trial and
rationale for the design should be attended by all recruit-
ing clinicians before they join the trial. We suggest that
this should be regularly reinforced during the course of
the study, especially in trials that do not use a straightfor-
ward placebo controlled experimental design.
Investigators keen to nurture and retain potential collabo-
rators may be inclined to waive attendance at training for
senior colleagues, but motivation to participate in prestig-
ious trials (such as the SST) remains relatively high; the
majority of these surgeons recognised the benefits of
being attached to a high profile MRC study. We can also
assume that the surgical community would not be the
only sector to benefit if awareness of appropriate trial
design were to be developed among clinicians.
The clinical question the trial is asking is most likely to be
understood and remembered if it is kept simple and rein-
forced by a simple strap line on all trial literature. With the
benefit of hindsight the title 'Spine Stabilisation Trial'
does not suggest a comparison of two equivalent treat-
ments – one surgical, one rehabilitation. Thus, it is per-
haps not so surprising that a few years later some
participating clinicians were often unable to recall the
involvement of the rehabilitation arm and were in a poor
position to interpret the significance of the results for their
own practice. A similar issue was raised in relation to the
UK Collaborative Neonatal ECMO Trial in which people
often referred to the trial and the experimental interven-
tion (ECMO) interchangeably [27].
In conclusion, does it matter if participating surgeons
didn't understand what the trial was about? We would
argue that it does if, as we have shown here, their percep-
tion of the trial aims and methods adversely affects who
they recruit; if their views affect what the patients are told;
and if they mistakenly view the results are unscientific,
unreliable and ultimately irrelevant to their practice.
Competing interests statement
JF and HF were involved in the design of the SST and JF,
HF and KB in its implementation.
Authors' contributions
JF, HF, KB and SZ were grant holders and designed the
study with advice from KF. SZ led this analysis with con-
siderable input from KF and CS, and drafted the paper. All
authors contributed to subsequent drafts and read and
approved the final version.
Note
Sue Ziebland is guarantor for this paper.
Ethical approval was granted by Eastern MREC.
We are grateful to the MRC for funding this study, to all
the surgeons who took part in the interviews and to Dor-
othy Pryce for her contribution to the fieldwork
References
1. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S,
Neal D, Hamdy F: Quality improvement report: Improving
design and conduct of randomised trials by embedding them
in qualitative research: ProtecT (prostate testing for cancer
and treatment) study. Commentary: presenting unbiased
information to patients can be difficult.  BMJ 2002,
5;325(7367):766-70.
2. Pollock AV: The rise and fall of the random controlled trial in
surgery.  Theor Surg 1989, 4:163-170.
3. Howes N, Chagla L, Thorpe M, McCulloch P: Br J Surg 1997,
84(9):1220-3.
4. Ko CY, Sack J, Chang JT, Fink A: Reporting randomized, control-
led trials: where quality of reporting may be improved.  Dis
Colon Rectum 2002, 45(4):443-7.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Trials 2007, 8:4 http://www.trialsjournal.com/content/8/1/4
Page 7 of 7
(page number not for citation purposes)
5. Solomon MJ, McLeod RS: Surgery and the randomised control-
led trial: past, present and future.  Med J Aust 1998,
169(7):380-3.
6. Horton R: Surgical research or comic opera: questions but
few answers.  Lancet 1996, 347:984-985.
7. Solomon MJ, McLeod RS: Should we be performing more rand-
omized controlled trials evaluating surgical operations?  Sur-
gery 1995, 118(3):459-67.
8. Curry JI, Reeves B, Stringer MD: Randomized controlled trials in
pediatric surgery: could we do better?  J Pediatr Surg 2003,
38(4):556-9.
9. Anyanwu AC, Treasure T: Surgical research revisited: clinical
trials in the cardiothoracic surgical literature.  Eur J Cardiotho-
rac Surg 2004, 25(3):299-303.
10. Stirrat GM : Ethics and evidence based surgery.  J Med Ethics
2004, 30(2):160-5. Review
11. Buchwald H: Surgical procedures and devices should be evalu-
ated in the same way as medical therapy.  Control Clin Trials
1997, 18(6):478-87.
12. Ehrlich PF, Newman KD, Haase GM, Lobe TE, Wiener ES, Holcomb
GW: Lessons learned from a failed multi-institutional rand-
omized controlled study.  J Pediatr Surg 2002, 37(3):431-6.
13. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D: Randomised
trials in surgery: problems and possible solutions.  BMJ 2002,
324(7351):1448-51.
14. Reitsma AM, Moreno JD: thical regulations for innovative sur-
gery: the last frontier?  J Am Coll Surg 2002, 194(6):792-801.
15. Margo CE: When is surgery research? Towards an operational
definition of human research.  J Med Ethics 2001, 27:40-43.
16. McLeod RS, Wright JG, Solomon MJ, Hu X, Walters BC, Lossing A:
Randomized controlled trials in surgery: Issues and prob-
lems.  Surgery 1996, 119(5):483-6.
17. Maddern GJ: Surgery and evidence-based medicine.  Med J Aust
1998, 5;169(7):348-9.
18. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D: Randomised
trials in surgery: problems and possible solutions.  BMJ 2002,
324(7351):1448-51.
19. Fallowfield L, Ratcliffe D, Souhami R: Clinicians' attitudes to clin-
ical trials of cancer therapy.  Eur J Cancer 1997, 33(13):2221-9.
20. Martin RC 2nd, Polk HC Jr, Jaques DP: Does additional surgical
training increase participation in randomized controlled tri-
als?  Am J Surg 2003, 185(3):239-43.
21. Millat B, Fingerhut A, Flamant Y, Hay JM, Fagniez PL, Farah A, Duron
JJ, Courchevel JM: Survey of the impact of randomised clinical
trials on surgical practice in France.  Eur J Surg 1999,
165(2):87-94.
22. Fairbank J, Frost H, Wilson-MacDonald J, Yu LM, Barker K, Collins R:
Spine Stabilisation Trial Group Randomised controlled trial
to compare surgical stabilisation of the lumbar spine with an
intensive rehabilitation programme for patients with
chronic low back pain: the MRC spine stabilisation trial.  BMJ
2005, 330:1233-1239.
23. Riviero-Arias O, Campbell H, Gray A, Fairbank J, Frost H, Wilson-
MacDonald J: Surgical stabilisation of the lumbar spine com-
pared with a programme of intensive rehabilitation for the
management of patients with chronic low back pain: cost
utility analysis based on a randomised controlled trial.  BMJ
2005, 330:1239-1243.
24. Pope C, Ziebland S, Mays N: Qualitative research in health care:
analysing qualitative data.  BMJ 2000, 320:114-6.
25. Garcia J, Elbourne DR, Snowdon C: Equipoise: a case study of the
views of clinicians involved in two neonatal trials.  Clin Trials
2004, 1(2):170-8.
26. Schwartz D, Lelouch J: Explanatory and pragmatic attitudes in
therapeutic trials.  Journal of Chronic Disease 1967, 20:637-48.
27. Snowdon C, Elbourne D, Garcia J: Making sense of randomisa-
tion; responses of parents of critically ill babies to random
allocation of treatment in a clinical trial.  Soc Sci Med 1997,
45:1337-55.
